Background/aims: Long non-coding RNAs (LncRNAs) have been validated to be pivotal mediators in multidrug resistance (MDR) of various cancers. This study aims to explore the roles and molecular mechanisms of linc00518 implicated in chemoresistance in breast cancer.
Methods: Expressions of linc00518, miR-199a and MRP1 were evaluated by RT-qPCR or western blot. IC50 values of adriamycin (ADR), vincristine (VCR) and paclitaxel (PTX) were determined by XTT assays and cell apoptosis was assessed by flow cytometry. Luciferase reporter and RIP assays were employed to detect the interaction of linc00518, miR-199a and MRP-1.
Results: linc00518 expression increased nearly 2 fold and MRP1 level elevated about 2.5 fold in breast cancer tissues as compared to that in adjacent normal tissues. Also, almost 2 fold upregulation of linc00518 and MRP-1 expressions was observed in MCF-7 cells than in MCF-10A cells. Additionally, linc00518 level was almost 2.5 fold higher and MRP1 level was about 2 fold increased in ADR-resistant MCF-7 cells (MCF-7/ADR) than in parental cell line MCF-7. Linc00518 knockdown enhanced chemosensitivity to ADR, VCR and PTX, and boosted ADR-, VCR- and PTX-induced apoptosis in MCF-7/ADR cells. miR-199a inhibitor conferred chemoresistance to ADR, VCR and PTX in MCF-7/ADR cells, and suppressing miR-199a reversed multi-drug susceptibility induced by linc00518 knockdown. Furthermore, linc00518 could act as a molecular sponge of miR-199a to repress MRP1 expression. MRP1 depletion increased the sensitivity of MCF-7/ADR cells to ADR, VCR and PTX, and this effect was attenuated following miR-199a inhibition or linc00518 overexpression. Also, linc00518 silencing increased ADR-mediated anti-tumor effect in vivo.
Conclusions: linc00518 downregulation reduced MDR by regulating miR-199a/MRP1 axis in breast cancer.
Download full-text PDF |
Source |
|---|---|
| http://dx.doi.org/10.1159/000491659 | DOI Listing |
Publication Analysis
Top Keywords
Similar Publications
Article Synopsis
- The study aimed to identify dermoscopic features that distinguish melanoma in situ (MIS) from atypical nevi (ATN) and assess the role of genomic biomarkers in patient management.
- Between 2018 and 2023, researchers evaluated 56 melanomas, analyzing various clinical and dermoscopic features along with melanoma-associated genomic biomarkers.
- The results indicated that dermoscopic features alone could not effectively differentiate MIS from ATN, but genomic testing improved the distinction between lower and higher-risk lesions for better clinical decision-making.
LINC00518: a key player in tumor progression and clinical outcomes.
Front Immunol
August 2024
Department of Oncology, The First Affiliated Hospital of Gannan Medical University, Ganzhou, Jiangxi, China.
Long non-coding RNAs (lncRNAs), defined as RNA molecules exceeding 200 nucleotides in length, have been implicated in the regulation of various biological processes and the progression of tumors. Among them, LINC00518, a recently identified lncRNA encoded by a gene located on chromosome 6p24.3, consists of three exons and is predicted to positively regulate the expression of specific genes.
View Article and Find Full Text PDFA signature of seven hypoxia-related lncRNAs is a potential biomarker for predicting the prognosis of melanoma.
Am J Cancer Res
April 2024
School of Traditional Chinese Medicine, Naval Medical University Shanghai, China.
Article Synopsis
- Melanoma is a highly aggressive skin cancer with a significant mortality rate, especially after metastasis, and its progression is driven by hypoxia in the tumor microenvironment.
- Recent research identified seven hypoxia-related long noncoding RNAs (lncRNAs) as potential biomarkers for predicting patient outcomes, leading to the development of a predictive risk model that groups patients by survival likelihood.
- The findings indicate that patients in the low-risk group have a better overall survival and response to immunotherapy, highlighting the potential of these lncRNAs as targets for treatment and indicators of prognosis in melanoma patients.
Tumor-infiltrating macrophage associated lncRNA signature in cutaneous melanoma: implications for diagnosis, prognosis, and immunotherapy.
Aging (Albany NY)
March 2024
Department of Ophthalmology, West China Hospital of Sichuan University, Chengdu, Sichuan, China.
Along with the increasing knowledge of long noncoding RNA, the interaction between the long noncoding RNA (lncRNA) and tumor immune infiltration is increasingly valued. However, there is a lack of understanding of correlation between regulation of specific lncRNAs and tumor-infiltrating macrophages within melanoma. In this research, a macrophage associated lncRNA signature was identified by multiple machine learning algorithms and the robust and effectiveness of signature also validated in other independent datasets.
View Article and Find Full Text PDFWant AI Summaries of new PubMed Abstracts delivered to your In-box?
Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!